Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study

被引：0
|
作者：
Clowse, Megan E. B. [1 ]
Forger, Frauke [2 ]
Hwang, Caroline [3 ]
Thorp, John [4 ]
Dolhain, Radbound J. E. M. [5 ]
van Tubergen, Astrid [6 ]
Teil, Marie [7 ]
Toublanc, Nathalie [7 ]
Hale, Thomas [7 ]
机构：
[1] Duke Univ, Sch Med, Durham, NC 27706 USA
[2] Univ Hosp Bern, Inselspital, Bern, Switzerland
[3] Keck Hosp USC, Los Angeles, CA USA
[4] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[5] Univ Med Ctr Rotterdam, Rotterdam, Netherlands
[6] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[7] Texas Tech Univ, Sch Med, Lubbock, TX 79409 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
4821
引用
收藏
页码：AB127 / AB127
页数：1
相关论文
共 50 条
  • [41] Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Active Non-Radiographic Axial Spondyloarthritis: 3-Year Results from a Phase 3 Multicenter Study
    van der Heijde, Desiree
    Gensler, Lianne
    Maksymowych, Walter
    Landewe, Robert
    Rudwaleit, Martin
    Bauer, Lars
    Hoepken, Bengt
    Kumke, Thomas
    Kim, Mindy
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1896 - 1899
  • [42] INITIAL RESULTS FROM A MULTICENTER PROSPECTIVE REGISTRY EVALUATING POUCH-RELATED OUTCOMES
    Barnes, Edward L.
    Deepak, Parakkal
    Beniwal-Patel, Poonam
    Raffals, Laura H.
    Kayal, Maia
    Dubinsky, Marla
    Chang, Shannon
    Higgins, Peter D.
    Barr, Jennifer I.
    Galanko, Joseph
    Cross, Raymond K.
    Long, Millie D.
    Herfarth, Hans H.
    GASTROENTEROLOGY, 2021, 160 (06) : S542 - S542
  • [43] Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study
    van der Horst-Bruinsma, Irene E.
    van Bentum, Rianne E.
    Verbraak, Frank D.
    Deodhar, Atul
    Rath, Thomas
    Hoepken, Bengt
    Irvin-Sellers, Oscar
    Thomas, Karen
    Bauer, Lars
    Rudwaleit, Martin
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [44] Certolizumab Pegol for the Treatment of Moderate to Severe Plaque Psoriasis: 16-Week Results from a Phase 2/3 Japanese Study
    Umezawa, Yoshinori
    Sakurai, Shinya
    Hoshii, Naoki
    Nakagawa, Hidemi
    DERMATOLOGY AND THERAPY, 2021, 11 (02) : 513 - 528
  • [45] Certolizumab Pegol Effectiveness in Crohn's Disease Patients with Secondary Failure to Infliximab Is Independent of Infliximab Dosing: Results from the WELCOME Study
    Abreu, Maria T.
    Vermeire, Severine
    Rutgeerts, Paul J.
    Ullman, Thomas A.
    Wolf, Douglas C.
    Sandborn, William J.
    GASTROENTEROLOGY, 2009, 136 (05) : A181 - A181
  • [46] Certolizumab Pegol for the Treatment of Moderate to Severe Plaque Psoriasis: 16-Week Results from a Phase 2/3 Japanese Study
    Yoshinori Umezawa
    Shinya Sakurai
    Naoki Hoshii
    Hidemi Nakagawa
    Dermatology and Therapy, 2021, 11 : 513 - 528
  • [47] Long-term remission with certolizumab pegol in Crohn's disease over 3.5 years: results from the PRECiSE 3 study
    Lichtenstein, G.
    Thomsen, O.
    Schreiber, S.
    Lawrance, I
    Hanauer, S.
    Bloomfield, R.
    Sandborn, W.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S12 - S13
  • [48] Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24-Week Patient-Reported Outcome Results of a Phase III, Multicenter Study
    Gladman, D.
    Fleischmann, R.
    Coteur, G.
    Woltering, F.
    Mease, P. J.
    ARTHRITIS CARE & RESEARCH, 2014, 66 (07) : 1085 - 1092
  • [49] Regain of Response and Remission by Dose Adjustment in Patients with Crohn's Disease Who Responded to Certolizumab Pegol: Results from the WELCOME Study
    Sandborn, William
    D'Haens, Geert
    Vermeire, Severine
    Colombel, Jean-Frederick
    Fedorak, Richard
    Spehlmann, Martina
    Wolf, Douglas
    Mitchev, Krassimir
    Jamoul, Corinne
    Abreu, Maria
    Rutgeerts, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S450 - S451
  • [50] AN INNOVATIVE REUSABLE ELECTRONIC INJECTION DEVICE FOR CERTOLIZUMAB PEGOL: RESULTS FROM A PILOT MARKET RESEARCH STUDY EXAMINING PATIENT PREFERENCE AND SATISFACTION
    Pouls, B. P.
    Kristensen, L. E.
    Petersson, M.
    van den Bemt, B. J.
    van Bracht, E.
    Bruggraber, R.
    Mountian, I
    Wiegratz, S.
    Karlen, H.
    Ballerini, L.
    Jorgensen, T. S.
    VALUE IN HEALTH, 2019, 22 : S679 - S680
12345